Intervention not reported
IUI · couples with unexplained infertility
The intervention showed no clear difference in IUI (low certainty).
1 finding from 1 review
OR 1.33 [0.67, 3.58]
Studies not reported
Low
Intervention not reported
OS‐IUI · couples with unexplained infertility
The intervention showed no clear difference in OS‐IUI (low certainty).
1 finding from 1 review
OR 1.17 [0.64, 2.12]
Studies not reported
Low
Intervention not reported
Comparator · couples with unexplained infertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Expectant management/IUI · couples with unexplained infertility
The intervention showed no clear difference in expectant management/IUI (low certainty).
1 finding from 1 review
OR 3.07 [1, 9.41]
Studies not reported
Low
Intervention not reported
OS · couples with unexplained infertility
It is very uncertain whether the intervention changes OS (very low certainty).
1 finding from 1 review
OR 1.09 [0.38, 3.15]
Studies not reported
Very low
Intervention not reported
OS‐IUI · couples with unexplained infertility
The intervention showed no clear difference in OS‐IUI (low certainty).
1 finding from 1 review
OR 0.8 [0.37, 1.73]
Studies not reported
Low
Intervention not reported
Interventions · people with hepatorenal syndrome with decompensated liver cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Albumin plus noradrenaline (1 RCT; 46 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 46 participants) (very low certainty).
1 finding from 1 review
OR 0.16 [0.01, 1.44]
Studies not reported
Very low
Intervention not reported
Albumin plus terlipressin · people with hepatorenal syndrome with decompensated liver cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Albumin plus noradrenaline (4 RCTs; 293 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
The intervention may leads to lower albumin plus noradrenaline (4 RCTs; 293 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Albumin (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Albumin plus noradrenaline (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
HR 1.09 [0.36, 3.31]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (10 RCTs; 518 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (10 RCTs; 518 participants) (very low certainty).
1 finding from 1 review
HR 0.85 [0.58, 1.28]
Studies not reported
Very low
Intervention not reported
Albumin (4 RCTs; 406 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (4 RCTs; 406 participants) (very low certainty).
1 finding from 1 review
HR 0.28 [0.14, 0.53]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (9 RCTs; 486 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (9 RCTs; 486 participants) (very low certainty).
1 finding from 1 review
HR 1.33 [0.87, 2]
Studies not reported
Very low
Intervention not reported
Albumin (6 RCTs; 480 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (6 RCTs; 480 participants) (very low certainty).
1 finding from 1 review
HR 1.06 [0.69, 1.8]
Studies not reported
Very low
Intervention not reported
Albumin plus midodrine plus octreotide (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus midodrine plus octreotide (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
HR 1.42 [0.52, 3.79]
Studies not reported
Very low
Intervention not reported
Albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) (very low certainty).
1 finding from 1 review
HR 0.5 [0.06, 4.07]
Studies not reported
Very low
Intervention not reported
Albumin plus octreotide (1 RCT; 40 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus octreotide (1 RCT; 40 participants) (very low certainty).
1 finding from 1 review
HR 1.46 [0.35, 6.49]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (1 RCT; 120 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 120 participants) (very low certainty).
1 finding from 1 review
OR 0.82 [0.21, 2.98]
Studies not reported
Very low